In the early phases of atherosclerosis, this is inhibited by AT1R blockers through their effects on toll-like receptors (TLRs), slowing down plaque development and improving plaque stability in experimental atherosclerosis [139]. This evidence concerns the gene AGTR1 and atherosclerosis.